{"id":"https://openalex.org/W4296468427","doi":"https://doi.org/10.1016/s2152-2650(22)01395-7","title":"MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS","display_name":"MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS","publication_year":2022,"publication_date":"2022-09-20","ids":{"openalex":"https://openalex.org/W4296468427","doi":"https://doi.org/10.1016/s2152-2650(22)01395-7"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(22)01395-7","doi":"https://doi.org/10.1016/s2152-2650(22)01395-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(22)01395-7","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035609080","display_name":"Amy Elizabeth Dezern","orcid":"https://orcid.org/0000-0001-5225-4609","observed_orcids":["https://orcid.org/0000-0001-5225-4609"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy DeZern","raw_affiliation_strings":["Johns Hopkins University, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014838075","display_name":"Pierre Fenaux","orcid":"https://orcid.org/0000-0002-0468-3553","observed_orcids":["https://orcid.org/0000-0002-0468-3553"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Fenaux","raw_affiliation_strings":["H\u00f4pital Saint Louis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Saint Louis, Paris, France","institution_ids":["https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054397552","display_name":"Dries Deeren","orcid":"https://orcid.org/0000-0001-9599-2142","observed_orcids":["https://orcid.org/0000-0001-9599-2142"]},"institutions":[{"id":"https://openalex.org/I4210144110","display_name":"AZ Delta","ror":"https://ror.org/04b0her22","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210144110"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Dries Deeren","raw_affiliation_strings":["AZ Delta, Roeselare, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AZ Delta, Roeselare, Belgium","institution_ids":["https://openalex.org/I4210144110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063154849","display_name":"Mar\u00eda D\u00edez\u2010Campelo","orcid":"https://orcid.org/0000-0002-1467-6779","observed_orcids":["https://orcid.org/0000-0002-1467-6779","https://orcid.org/0000-0003-0386-4835"]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Diez Campelo","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047951694","display_name":"Michael L\u00fcbbert","orcid":"https://orcid.org/0000-0003-1186-1650","observed_orcids":["https://orcid.org/0000-0003-1186-1650"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael L\u00fcbbert","raw_affiliation_strings":["Universit\u00e4tKlinikum Freiburg, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e4tKlinikum Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011143459","display_name":"Pramila Krishnamurthy","orcid":"https://orcid.org/0000-0001-7069-3867","observed_orcids":["https://orcid.org/0000-0001-7069-3867"]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Pramila Krishnamurthy","raw_affiliation_strings":["King's College Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zsolt Nagy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Zsolt Nagy","raw_affiliation_strings":["Semmelweis University, Department of Internal Medicine and Hematology, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Semmelweis University, Department of Internal Medicine and Hematology, Budapest, Hungary","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053012296","display_name":"Grzegorz W\u0142adys\u0142aw Basak","orcid":"https://orcid.org/0000-0003-3858-8180","observed_orcids":["https://orcid.org/0000-0003-3858-8180"]},"institutions":[{"id":"https://openalex.org/I268303160","display_name":"Medical University of Warsaw","ror":"https://ror.org/04p2y4s44","country_code":"PL","type":"education","lineage":["https://openalex.org/I268303160"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Grzegorz Basak","raw_affiliation_strings":["Medical University of Warsaw, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Warsaw, Warsaw, Poland","institution_ids":["https://openalex.org/I268303160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002183416","display_name":"Anna Jon\u00e1\u0161 ov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162037","display_name":"General University Hospital in Prague","ror":"https://ror.org/04yg23125","country_code":"CZ","type":"funder","lineage":["https://openalex.org/I4210162037"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Anna Jon\u00e1\u0161 ov\u00e1","raw_affiliation_strings":["General University Hospital Prague, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General University Hospital Prague, Prague, Czech Republic","institution_ids":["https://openalex.org/I4210162037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077151480","display_name":"Klaus H. Geissler","orcid":"https://orcid.org/0000-0003-1921-7034","observed_orcids":["https://orcid.org/0000-0003-1921-7034"]},"institutions":[{"id":"https://openalex.org/I4210089076","display_name":"Klinik Hietzing","ror":"https://ror.org/00621wh10","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210089076","https://openalex.org/I4210117134"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Klaus Geissler","raw_affiliation_strings":["Hospital Hietzing, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Hietzing, Vienna, Austria","institution_ids":["https://openalex.org/I4210089076"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032731817","display_name":"Yishai Ofran","orcid":"https://orcid.org/0000-0002-5521-1337","observed_orcids":["https://orcid.org/0000-0002-5521-1337"]},"institutions":[{"id":"https://openalex.org/I197251160","display_name":"Hebrew University of Jerusalem","ror":"https://ror.org/03qxff017","country_code":"IL","type":"education","lineage":["https://openalex.org/I197251160"]},{"id":"https://openalex.org/I2801962034","display_name":"Shaare Zedek Medical Center","ror":"https://ror.org/04d0szq68","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2801962034"]},{"id":"https://openalex.org/I2802879425","display_name":"Bikur Cholim Hospital","ror":"https://ror.org/03zpnb459","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2802879425"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Yishai Ofran","raw_affiliation_strings":["Department of Hematology, Shaare Zedek Medical Center, Faculty of Medicine Hebrew University of Jerusalem, Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Shaare Zedek Medical Center, Faculty of Medicine Hebrew University of Jerusalem, Jerusalem, Israel","institution_ids":["https://openalex.org/I197251160","https://openalex.org/I2801962034","https://openalex.org/I2802879425"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108616758","display_name":"Angela Volkert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Volkert","raw_affiliation_strings":["Syros Pharmaceuticals, Inc, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Inc, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kristen Baker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen Baker","raw_affiliation_strings":["Syros Pharmaceuticals, Inc, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Inc, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007748320","display_name":"Jaime Chisholm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaime Chisholm","raw_affiliation_strings":["Syros Pharmaceuticals, Inc, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Inc, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013312474","display_name":"Qing Kang-Fortner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qing Kang-Fortner","raw_affiliation_strings":["Syros Pharmaceuticals, Inc, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Inc, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David A. Roth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Roth","raw_affiliation_strings":["Syros Pharmaceuticals, Inc, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Inc, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101429413","display_name":"MICHAEL J. KELLY","orcid":"https://orcid.org/0000-0003-4552-7546","observed_orcids":["https://orcid.org/0000-0003-4552-7546"]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Kelly","raw_affiliation_strings":["Syros Pharmaceuticals, Inc, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Inc, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025719686","display_name":"Giovanni Marconi","orcid":"https://orcid.org/0000-0001-6309-0515","observed_orcids":["https://orcid.org/0000-0001-6309-0515"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Marconi","raw_affiliation_strings":["Romagnolo Institute to Study Tumors \u201cDino Amadori\u201d, Meldola, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Romagnolo Institute to Study Tumors \u201cDino Amadori\u201d, Meldola, Italy","institution_ids":["https://openalex.org/I4210097834"]}]}],"institutions":[],"countries_distinct_count":12,"institutions_distinct_count":15,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3240,"currency":"USD","value_usd":3240},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":"S303","last_page":"S304"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tamibarotene","display_name":"tamibarotene","score":0.9390000104904175},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9559999704360962},{"id":"https://openalex.org/keywords/higher-risk-myelodysplastic-syndromes","display_name":"high-risk myelodysplastic syndrome","score":0.9649999737739563},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8080000281333923},{"id":"https://openalex.org/keywords/transfusion-independence","display_name":"transfusion independence","score":0.8370000123977661},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8450000286102295},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.6700000166893005},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8270000219345093},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.35600000619888306},{"id":"https://openalex.org/keywords/biomarker-guided-therapy","display_name":"biomarker-guided therapy","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.8421163558959961},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7045999765396118},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6991998553276062},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5675466656684875},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5531559586524963},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4726402163505554},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.46914997696876526},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45348379015922546},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.45092082023620605},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.24538245797157288},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0695151686668396},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(22)01395-7","doi":"https://doi.org/10.1016/s2152-2650(22)01395-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(22)01395-7","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281916232","https://openalex.org/W4410140459","https://openalex.org/W4283382756","https://openalex.org/W4300980184","https://openalex.org/W4310963082","https://openalex.org/W4385780217","https://openalex.org/W4296468343","https://openalex.org/W4310127720","https://openalex.org/W4286295251","https://openalex.org/W4401877373"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-09-21T00:00:00"}